Dionisia Quiroga, DO, PhD, FASCO
@quirogad.bsky.social
Breast medical oncologist & assistant professor @OSUCCC_James Opinions expressed are my own She/Her/Ella #bcsm #OncSky #MedSky
Thank you so much for this honor! Volunteering with @ascocancer.bsky.social has been a big joy in my career and happy to continue many future years of service!
American Society of Clinical Oncology@ascocancer.bsky.social · last yr.Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wUiSd
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wUiSd
Thanks to these wonderful running buddies @drgattimays.bsky.social & @quirogad.bsky.social & @oncoalert.bsky.social for making it all happen!!
Margaret Gatti-Mays, MD MPH@drgattimays.bsky.social · last yr.@oncoalert.bsky.social annual #ASCO25 5K on a beautiful morning in Chicago! Had some great running partners this am @quirogad.bsky.social @christeeny513.bsky.social
Perfect #ASCO25 morning - beautiful Chicago lakeside run with two amazing leaders in breast cancer care and advocacy 🏃♀️🙏🏽 @christeeny513.bsky.social @drgattimays.bsky.social @oncoalert.bsky.social @ascocancer.bsky.social
Margaret Gatti-Mays, MD MPH@drgattimays.bsky.social · last yr.@oncoalert.bsky.social annual #ASCO25 5K on a beautiful morning in Chicago! Had some great running partners this am @quirogad.bsky.social @christeeny513.bsky.social
#ASCO25 is right around the corner! ✨With >40K registrants, how can you best stand out of the crowd and make meaningful connections during the conference?✨ Here are some tips for trainees & early-career oncologists: connection.asco.org/do/networkin... @ascocancer.bsky.social @ascopost.bsky.social
Networking at ASCO25: Strategies for Success
Dr. Dionisia Quiroga shares her tips for making the 2025 ASCO Annual Meeting a networking triumph for early-career oncology professionals.
connection.asco.org
Today family picture with some of the 87 amazing faculty of our Division of Medical Oncology at The James CCC. Very honored to be part and lead this incredible team! @OhioStateMedOnc @OSUCCC_James @OhioStateMed @drgattimays.bsky.social @stoverlab.bsky.social
Honored and grateful for the opportunity to discuss 3 oral abstracts at #ASCO25 and represent #OSUCCC @osucccjames.bsky.social @osuwexmed.bsky.social #Immunotherapy @sitcancer.bsky.social #PIIO @ascocancer.bsky.social
Sacituzumab + Pembro in ASCENT04 improves Progression Free Survival in Patients With Previously Untreated PD-L1 Metastatic Triple-Negative Breast Cancer #bcsm www.gilead.com/news/news-de... @oncoalert.bsky.social
Trodelvy Plus Keytruda Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD L1 Metastatic Triple Negativ...
Trodelvy Plus Keytruda Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD L1 Metastatic Triple Negativ...
gilead.com
My hometown 🙏🏽 Vaccinations work; please protect yourself and others
Dr. Zachary Rubin@rubinallergy.bsky.social · last yr.Measles case in Michigan reported. A baby may have exposed a lot of people recently.
🚨We are hiring Medical Oncologists at @OhioStateMedOnc ! Check the QR code below for the available positions! 3 pathways: - Physician Scientist - Clinical Scholar - Clinical Excellence Send your applications @OSUCCC_James @OhioStateMed
From 2010 to 2016 (latest data I have ), NIH research contributed to EVERY drug approved by the FDA
Cancer researchers working on health disparities say President Trump's actions could hurt rural whites, who lag behind other groups in cancer screening.
Trump wants to erase DEI. Researchers worry it will upend work on health disparity
Cancer researchers working on health disparities say President Trump's actions could hurt rural whites, who lag behind other groups in cancer screening.
npr.org
Deadline approaching! The #SITC Women in Cancer Immunotherapy Network Leadership Institute applications close March 24. Don’t miss your opportunity to participate in panel discussions and presentations from experienced female leaders. Learn more here: www.sitcancer.org/professional...
NIH indirects case update: Hearing ongoing now, and I'll try to live tweet some notable exchanges. Prior to more detailed arguments, Judge Kelley starts off with a few point questions to both sides: (I'm paraphrasing here)
Discuss real-world case studies with clinical experts! #SITC’s ACI: Women’s Malignancies program will explore practical insights to apply immunotherapy into clinical practice. Join Feb. 28 for a free CME program. Register now: ow.ly/bTFn50UYy9j @drgattimays.bsky.social @veredstearns.bsky.social
In Ohio during FY23 (2022-2023) this was the impact of NIH funding: $1.01 Billion in grants and contracts $2.05 Billion in economic support 13,061 jobs supported This reduction in NIH indirect will decimate research and limit health care advances www.unitedformedicalresearch.org/nih-in-your-...
NIH In Your State - United For Medical Research
Select a state on the map to see the impact of NIH funding across America.
unitedformedicalresearch.org
1. Today the NIH director issued a new directive slashing overhead rates to 15%. I want to provide some context on what that means and why it matters. grants.nih.gov/grants/guide...
NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates NOT-OD-25-068. OD
grants.nih.gov
Great session with Dr Heather McArthur on treating early stage #TNBC #IO posted on #ReachMD @osuwexmed.bsky.social @osucccjames.bsky.social reachmd.com/programs/cme...
Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care
Tune in for a deep dive into the evolving landscape of immuno-oncology (IO) in early-stage triple-negative breast cancer (TNBC). Our experts focus on identifying eligible patients for neoadjuvant and ...
reachmd.com
200 participants at OSU SABCS meeting - Christian Rolfo @christianrolfo.bsky.social @stoverlab.bsky.social @quirogad.bsky.social oncodaily.com/blog/237555 #BreastCancer #Cancer #FightAgainstCancer #MedOnc #OncoDaily #Oncology #OSU #SABCSmeeting #Medicine #Health
Christian Rolfo: 200 participants at OSU SABCS meeting - OncoDaily
Christian Rolfo: 200 participants at OSU SABCS meeting / Breast Cancer, cancer, Christian Rolfo, Daniel Stover, Dionisia Quiroga, fight against cancer, Global
oncodaily.com
Dr. Quiroga, we're delighted to have you on the expert panel and look forward to your presentation on immunotherapy for late-stage breast cancer!
Dionisia Quiroga, DO, PhD, FASCO@quirogad.bsky.social · 2y ago📚🎙️Come discuss updates and the future of IO use in #MBC with me on Feb 28th! A++ group of #breastonc #gynonc speakers and great opportunity for CME/MOC and other ed credits @sitcancer.bsky.social #LearnACI #bcsm @drgattimays.bsky.social @osucccjames.bsky.social
Happy to share our retrospective study on #pneumonitis risk in patients with #breastcancer who receive #TDXd #Enhertu @stoverlab.bsky.social @osucccjames.bsky.social #bcsm
Evaluating risk factors for Trastuzumab-Deruxtecan Pneumonitis in patients with metastatic breast cancer - Breast Cancer Research
Background Trastuzumab deruxtecan (T-DXd) is FDA-approved for treatment of patients with HER2 positive and HER2-low metastatic breast cancer. Currently, there is limited understanding of pre-treatment...
breast-cancer-research.biomedcentral.com
Recognizing the brilliant #WomenInMedicine today 2/3/25 who continue to persevere, break glass ceilings and improve healthcare #NWPD25 #IamBlackwell @quirogad.bsky.social @aryaroy.bsky.social @nerealliamd.bsky.social @drsgraff.bsky.social @drsarahsammons.bsky.social @maryamlustberg.bsky.social
🎉Reunion w/ my co-fellow @jasminesukumar.bsky.social @mdanderson.bsky.social to discuss early #breastcancer adj tx w/ path germline muts on the @ascocancer.bsky.social Daily News podcast 👉Who needs testing? 👉OLYMPIA updates 👉Concurrent PARPi use w/ other adj tx ascodaily.libsyn.com/advances-in-...
ASCO Daily News: Advances in Adjuvant Therapy for High-Risk Early Breast Cancer With Germline Mutations
Dr. Jessica Sukumar and Dr. Dionisia Quiroga discuss advances in adjuvant therapy for patients with early breast cancer and BRCA1/2 mutations, including how to identify patients who should receive gen...
ascodaily.libsyn.com
📚🎙️Come discuss updates and the future of IO use in #MBC with me on Feb 28th! A++ group of #breastonc #gynonc speakers and great opportunity for CME/MOC and other ed credits @sitcancer.bsky.social #LearnACI #bcsm @drgattimays.bsky.social @osucccjames.bsky.social
Society for Immunotherapy of Cancer@sitcancer.bsky.social · 2y ago#Immunotherapy for women’s malignancies continue to evolve. #SITC’s ACI: A Focus on Women’s Malignancies program provides clinicians with current updates in the use of IO to treat early/late-stage breast cancer. Join Feb. 28. Register: www.sitcancer.org/education/ac... #LearnACI #breastcancer
OSU SABCS meeting - 200 participants in attendance. Great turn out and awesome presentations by our amazing Breast Cancer team. Very proud of them 🙂👏 @OhioStateMedOnc @StoverLab @quirogad @CherianMathew30 Maggie Gatti-Myes and all team! #SABCS24 @OSUCCC_James @OhioStateMed
Love working with this group of talented docs! (We are so in sync we color coordinated without planning it #ScarletandGrey) @osucccjames.bsky.social
Margaret Gatti-Mays, MD MPH@drgattimays.bsky.social · 2y agoAmazing group of medical oncologists that I am privileged to work with every day and call friends @stoverlab.bsky.social @aryaroy.bsky.social @nerealliamd.bsky.social @quirogad.bsky.social @osucccjames.bsky.social
⏱️ The next cancer cure is on hold. @NIH grants invest in future science gains that pay back for our citizens at a rate of more than 2:1 in economic activity. We are losing the battle for discovery.
Trump hits NIH with ‘devastating’ freezes on meetings, travel, communications, and hiring
Researchers facing
science.org
Excellent advocacy program with Living Beyond Breast Cancer (LBBC) specific to patients living with stage IV/metastatic disease! This program was the foundation for my advocacy work and you'll meet some pretty amazing peeps along the way as well ♥️ bit.ly/3tEqyP9
